Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of the open offer

4 Apr 2016 10:17

RNS Number : 0454U
Scancell Holdings Plc
04 April 2016
 

04 April 2016

 

Scancell Holdings Plc

("Scancell" or the "Company")

 

Result of the open offer

 

On 1 April 2016 the Board of Scancell announced that it had received subscriptions in respect of 16,048,593 new Ordinary Shares of the 22,495,068 new Ordinary Shares available under the Open Offer.

 

The Company has now received applications for an additional 558,823 new Ordinary Shares, available but not subscribed for by Qualifying Shareholders in the Open Offer, therefore the revised total subscription under the Open Offer is 16,607,416 new Ordinary Shares, representing 73.8 per cent. the new Ordinary Shares available under the Open Offer. The Company has therefore raised gross proceeds of approximately £2.8 million through the Open Offer and £3.4 million through the Placing being approximately £6.2 million in total.

 

Application will be made to the London Stock Exchange for the admission to trading on AIM of the 36,607,416 new Ordinary Shares to be issued under the Placing and Open Offer. It is expected that Admission will occur and that dealings will commence at 08:00 a.m. on 5 April 2016. The total number of Ordinary Shares following Admission will be 261,558,099 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in Scancell under the FCA's Disclosure and Transparency Rules.

 

This announcement should be read in conjunction with the full text of the Circular posted to Shareholders on 11 March 2016, copies of which are available on the Company's website at www.scancell.co.uk. Capitalised terms not otherwise defined in this announcement have the meanings given in the Circular. 

 

 

For further information please contact:

 

Scancell Holdings Plc

Dr Richard Goodfellow, Joint CEO

Professor Lindy Durrant, Joint CEO

+44 (0) 20 3727 1000

Panmure Gordon (Nominated Adviser and placing agent)

Robert Naylor/Paul Fincham, Corporate Finance

Maisie Atkinson, Sales

+44 (0) 20 7886 2500

Lesmoir-Gordon, Boyle & Co. Limited (Sub placing agent)

Angus Grierson

+44 (0) 20 7518 9892

FTI Consulting

Mo Noonan

Simon Conway

+44 (0) 20 3727 1000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMMGGDLDFGVZG
Date   Source Headline
27th Oct 20204:36 pmRNSPrice Monitoring Extension
26th Oct 202010:10 amRNSConversion of Convertible Loan Notes
21st Oct 20204:12 pmRNSNotice of Annual General Meeting
16th Oct 20207:00 amRNSFinal Results for the year ended 30 April 2020
15th Oct 202011:10 amRNSHolding(s) in Company
14th Oct 202011:36 amRNSHolding(s) in Company
13th Oct 202012:07 pmRNSPosting of Circular
12th Oct 20207:00 amRNSProposed investment by Redmile and Open Offer
5th Oct 20207:00 amRNSNotice of Final Results
2nd Oct 20207:00 amRNSCollaboration to manufacture COVID-19 vaccine
24th Sep 20207:00 amRNSDirectorate Change
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20209:05 amRNSSecond Price Monitoring Extn
14th Sep 20209:00 amRNSPrice Monitoring Extension
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
8th Sep 20204:40 pmRNSSecond Price Monitoring Extn
8th Sep 20204:35 pmRNSPrice Monitoring Extension
4th Sep 20207:00 amRNSDirector Award of Share Options
27th Aug 20207:00 amRNSFunds awarded by Innovate UK for COVID-19 vaccine
26th Aug 20204:02 pmRNSHolding(s) in Company
25th Aug 202010:11 amRNSHolding(s) in Company
12th Aug 20203:13 pmRNSHolding(s) in Company
12th Aug 202012:57 pmRNSDirector Dealing
11th Aug 202010:54 amRNSResults of General Meeting
23rd Jul 20204:44 pmRNSShareholder circular
22nd Jul 20201:51 pmRNSResult of Placing and Notice of General Meeting
22nd Jul 20207:00 amRNSProposed Capital Raise
24th Jun 20207:00 amRNSNew publication highlights potential of Modi-1
12th Jun 20209:30 amRNSPublication highlights potential of AvidiMab
1st May 20207:00 amRNSDirector salaries and award of share options
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:00 pmRNSPrice Monitoring Extension
28th Apr 202010:06 amRNSDirector Dealing
27th Apr 20204:39 pmRNSDirector Dealing
24th Apr 20202:05 pmRNSSecond Price Monitoring Extn
24th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSScancell: Development of vaccine against COVID-19
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSScancell to Present at Three Research Conferences
3rd Feb 20207:00 amRNSSCIB1 IND Application Approved
31st Jan 20207:00 amRNSInterim Results
20th Jan 20207:00 amRNSThird agreement signed for antibody platform
17th Dec 201912:44 pmRNSDirector's Dealings
16th Dec 20197:00 amRNSSecond agreement signed for AvidiMab platform
20th Nov 20197:00 amRNSNew European Moditope patent allowed for grant
23rd Oct 20197:00 amRNSDirectorate Change
26th Sep 20197:00 amRNSPosters at Cancer Immunotherapy Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.